Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

High uptake of HIV testing in pregnant women in Ontario, Canada.

Remis RS, Merid MF, Palmer RW, Whittingham E, King SM, Danson NS, Vernich L, Swantee C, Major C.

PLoS One. 2012;7(11):e48077. doi: 10.1371/journal.pone.0048077. Epub 2012 Nov 9.

2.

A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.

Anonychuk AM, Bauch CT, Merid MF, Van Kriekinge G, Demarteau N.

BMC Public Health. 2009 Oct 31;9:401. doi: 10.1186/1471-2458-9-401.

3.

Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness.

Bauch CT, Anonychuk AM, Van Effelterre T, Pham BZ, Merid MF.

Med Decis Making. 2009 Sep-Oct;29(5):557-69. doi: 10.1177/0272989X09334419. Epub 2009 Jul 15.

PMID:
19605882
4.

Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.

Lampinen TM, Chan K, Remis RS, Merid MF, Rusch M, Vincelette J, Logue K, Popovic V, Alary M, Schechter MT, Hogg RS.

CMAJ. 2005 Feb 15;172(4):479-83.

5.
6.

Supplemental Content

Loading ...
Support Center